Foxhaven is a limited partnership organized under the laws of the State of Delaware to provide investment management services to several related pooled investment vehicles. Formed in April 2013, Foxhaven is owned and controlled by Michael Pausic and Nicholas Lawler (the “Principals”). The investment activities of Foxhaven are led by the Principals together with other investment professionals who assist in executing the investment strategy. Foxhaven’s officers, Principals, partners, employees, and other persons who provide investment advice on behalf of Foxhaven and are subject to Foxhaven’s supervision and control are herein referred to as (the “Employees”). Foxhaven serves as an investment manager and provides discretionary advisory services to several related collective investment vehicles, including private investment partnerships and foreign investment companies organized as a master-feeder structure and private investment partnerships investing in parallel therewith (each, a “Fund” or “Client” or collectively the “Funds” or “Clients”). Foxhaven serves as investment manager to a master fund, and substantially all investing by the master fund and any feeder funds will be done at the master fund level. Typically, within each partnership structure is a designated general partner or manager (the “General Partner(s)”). Unless and only to the extent that the context otherwise requires, references to Foxhaven includes the General Partner(s). In providing services to the Funds, among other things, Foxhaven (i) manages the Funds’ assets in accordance with the terms of the confidential offering and/or private placement memoranda, individual limited partnership or shareholder agreements and other governing documents applicable to each Fund (the “Governing Documents”); (ii) formulates investment objectives; (iii) directs and manages the investment and reinvestment of the Funds’ assets; and (iv) provides periodic reports to Investors. Foxhaven provides investment advice directly to the Funds and not individually to a Fund’s limited partners or investors (the “Investors”). Investment

restrictions for the Funds, if any, are generally established in the applicable Fund’s governing documents. The investment objective of the Funds is to achieve superior risk-adjusted absolute returns over a horizon of three or more years. The Funds plan to pursue the investment objective through investing all or substantially all of their assets in, or in parallel with, the master fund. The master fund intends to pursue a fundamental long-short equity strategy with a global focus on the TMT, consumer and industrials sectors. From time to time, the Fund may, to the extent permitted by the Rules of the U.S. Financial Industry Regulatory Authority (“FINRA”) as may be amended from time to time (the “Rules”), purchase equity securities that are part of an initial public offering (sometimes referred to as “IPOs” or “new issues”). Under the Rules, brokers may not sell such securities to a private investment fund, if the fund has Investors who are “Restricted Persons”, which category includes persons employed by or affiliated with a broker and portfolio managers of hedge funds and other registered and unregistered investment advisory firms, unless the fund has a mechanism in place that excludes such Restricted Persons from receiving allocations of profits from new issues. The profits and losses with respect to new issues will generally be allocated to Investors in the Fund that are eligible to receive new issue allocations. Shares or limited partnership interests in the Funds are not registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and the Funds are not registered under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Accordingly, interests or shares in the Funds are offered and sold exclusively to Investors satisfying the applicable eligibility and suitability requirements, either in private transactions within the United States or in offshore transactions. As of December 31, 2023, Foxhaven had $5.607 billion in regulatory assets under management, all of which are managed on a discretionary basis.